首页 > 最新文献

Urologiia最新文献

英文 中文
[Renal injury during combination immunotherapy (ipilimumab + nivolumab) in patients with metastatic renal cell cancer who previously underwent nephrectomy]. [既往行肾切除术的转移性肾癌患者联合免疫治疗(易普利姆单抗+纳武单抗)期间的肾损伤]。
Q4 Medicine Pub Date : 2025-03-01
S Titov K, V Epifanova M, A Alimov A, Yu Nesterova O, V Shutov E, M S Lebedev S

Aim: To estimate frequency and type of renal injury in patients with metastatic renal cell carcinoma (RCC) receiving ipilimumab and nivolumab after nephrectomy.

Materials and methods: The retrospective study involved 50 patients, including 38 (76%) men and 12 (24%) women with a single kidney and progressive metastatic RCC. After nephrectomy before the start of immunotherapy for the progression of RCC, chronic kidney disease (CKD) stage 3 and higher was diagnosed in 39 (78%) cases.

Results: During immunotherapy, acute kidney injury (AKI) developed in 9 (11%) patients after 14 weeks of treatment. The maximum incidence of AKI (n=7; 25%) was documented after the 10th administration of the drugs. When assessing the dynamics of creatinine levels over 28 weeks, a significant increase was noted after the 2nd, 3rd, 4th and 10th administrations. After the 2nd administration of the drugs, the creatinine level in the total sample of patients increased on average to 159.7 mol/l with a baseline level of 127.8 mol/l (p<0.001), while after the 3rd, 4th and 10th administration to 160.3, 151.6 and 147.9 mol/l, respectively (p<0.039, p=0.003 and p=0.029, respectively). Similar dynamics were also seen for urea with a significant increase after the 2nd, 3rd, 4th, 5th and 7th administrations. For example, the maximum urea level was recorded after the 3rd and 5th administrations of the drugs and was 10.2 mmol/l, while before the start of therapy it was 8.1 mmol/l (p=0.001 and p=0.003, respectively).

Conclusion: A significant renal injury was seen during 28 weeks of follow-up in patients with metastatic RCC after nephrectomy receiving ipilimumab and nivolumab.

目的:评估转移性肾癌(RCC)患者在肾切除术后接受伊匹单抗和纳沃单抗治疗时肾损伤的频率和类型。材料和方法:回顾性研究涉及50例患者,包括38例(76%)男性和12例(24%)女性,均为单肾进展性转移性肾细胞癌。在开始免疫治疗肾癌进展前进行肾切除术后,39例(78%)慢性肾脏疾病(CKD) 3期及以上被诊断。结果:在免疫治疗期间,9例(11%)患者在治疗14周后发生急性肾损伤(AKI)。AKI的最大发生率(n=7;25%)在第10次给药后记录。当评估肌酐水平在28周内的动态变化时,在第2次、第3次、第4次和第10次用药后,肌酐水平显著升高。第二次给药后,患者总样本肌酐水平平均升高至159.7 mol/l,基线水平为127.8 mol/l(结论:在接受伊匹单抗和纳沃单抗治疗的肾切除后转移性肾癌患者,在28周的随访中发现了明显的肾损伤。
{"title":"[Renal injury during combination immunotherapy (ipilimumab + nivolumab) in patients with metastatic renal cell cancer who previously underwent nephrectomy].","authors":"S Titov K, V Epifanova M, A Alimov A, Yu Nesterova O, V Shutov E, M S Lebedev S","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>To estimate frequency and type of renal injury in patients with metastatic renal cell carcinoma (RCC) receiving ipilimumab and nivolumab after nephrectomy.</p><p><strong>Materials and methods: </strong>The retrospective study involved 50 patients, including 38 (76%) men and 12 (24%) women with a single kidney and progressive metastatic RCC. After nephrectomy before the start of immunotherapy for the progression of RCC, chronic kidney disease (CKD) stage 3 and higher was diagnosed in 39 (78%) cases.</p><p><strong>Results: </strong>During immunotherapy, acute kidney injury (AKI) developed in 9 (11%) patients after 14 weeks of treatment. The maximum incidence of AKI (n=7; 25%) was documented after the 10th administration of the drugs. When assessing the dynamics of creatinine levels over 28 weeks, a significant increase was noted after the 2nd, 3rd, 4th and 10th administrations. After the 2nd administration of the drugs, the creatinine level in the total sample of patients increased on average to 159.7 mol/l with a baseline level of 127.8 mol/l (p<0.001), while after the 3rd, 4th and 10th administration to 160.3, 151.6 and 147.9 mol/l, respectively (p<0.039, p=0.003 and p=0.029, respectively). Similar dynamics were also seen for urea with a significant increase after the 2nd, 3rd, 4th, 5th and 7th administrations. For example, the maximum urea level was recorded after the 3rd and 5th administrations of the drugs and was 10.2 mmol/l, while before the start of therapy it was 8.1 mmol/l (p=0.001 and p=0.003, respectively).</p><p><strong>Conclusion: </strong>A significant renal injury was seen during 28 weeks of follow-up in patients with metastatic RCC after nephrectomy receiving ipilimumab and nivolumab.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"68-74"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Testosterone replacement therapy for male hypogonadism: a view from the 21st century]. [睾酮替代疗法治疗男性性腺功能减退:来自21世纪的观点]。
Q4 Medicine Pub Date : 2025-03-01
I Rasner P, A Reva I, I Karamysheva E, I Aliev R

The prevalence of symptomatic post-pubertal hypogonadism in men 40-79 is 2,1-5,7% and increases with age. The aim of testosterone replacement therapy is to restore testosterone levels in blood plasma to normal physiological averages and provide numerous positive clinical effects: improved sexual function, reduced symptoms of depression, improved mood, normalization of the muscle-fat ratio of body composition and bone mineral density, and many others. The recommendations of various testosterone therapy manuals did not allow us to form an unambiguous opinion on the safety of long-term testosterone replacement therapy. The main purpose of the present work is to analyze the effectiveness of testosterone replacement therapy in the treatment of the main symptoms of post-pubertal hypogonadism, its effect on concomitant somatic pathology, safety and a reasonable choice of the dosage form of the testosterone preparation.

40-79岁男性青春期后性腺功能减退的患病率为2,1-5,7%,随年龄增长而增加。睾酮替代疗法的目的是将血浆中的睾酮水平恢复到正常的生理平均水平,并提供许多积极的临床效果:改善性功能,减轻抑郁症状,改善情绪,使身体成分的肌肉脂肪比例和骨矿物质密度正常化,以及许多其他方面。各种睾酮治疗手册的建议并没有让我们对长期睾酮替代治疗的安全性形成明确的意见。本研究的主要目的是分析睾酮替代疗法治疗青春期后性腺功能减退主要症状的有效性、对伴发性腺病理的影响、睾酮制剂的安全性及剂型的合理选择。
{"title":"[Testosterone replacement therapy for male hypogonadism: a view from the 21st century].","authors":"I Rasner P, A Reva I, I Karamysheva E, I Aliev R","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The prevalence of symptomatic post-pubertal hypogonadism in men 40-79 is 2,1-5,7% and increases with age. The aim of testosterone replacement therapy is to restore testosterone levels in blood plasma to normal physiological averages and provide numerous positive clinical effects: improved sexual function, reduced symptoms of depression, improved mood, normalization of the muscle-fat ratio of body composition and bone mineral density, and many others. The recommendations of various testosterone therapy manuals did not allow us to form an unambiguous opinion on the safety of long-term testosterone replacement therapy. The main purpose of the present work is to analyze the effectiveness of testosterone replacement therapy in the treatment of the main symptoms of post-pubertal hypogonadism, its effect on concomitant somatic pathology, safety and a reasonable choice of the dosage form of the testosterone preparation.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"93-103"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Decompression of upper urinary tract in various pathological conditions]. 【不同病理条件下的上尿路减压】。
Q4 Medicine Pub Date : 2025-03-01
M Khokhov Z

Obstruction of the upper urinary tract (UUT) is a heterogeneous clinical case, which, if necessary or in case of complications, is relieved by percutaneous nephrostomy or ureteral JJ-stent placement, which have its "pros and cons" in relation to complications, costs, difficulties in performing various pathological conditions, quality of life of patients and further treatment. The European Association of Urology Guidelines on Urolithiasis 2024 are based on the 2010s data review., fourteen years later, the optimal method of UUT decompression in various pathological conditions remains under debate. In this lecture we present methods, indications, contraindications, complications, quality of life of patients under various methods of UUT draining, as well as the benefits of ureteral stenting and percutaneous nephrostomy.

上尿路梗阻(UUT)是一种异质性的临床病例,如有必要或出现并发症时,可通过经皮肾造口术或输尿管jj -支架置入术予以缓解,这在并发症、费用、实施各种病理条件的困难、患者的生活质量和进一步治疗等方面都有其“利弊”。2024年欧洲泌尿外科协会尿石症指南是基于2010年的数据回顾。, 14年后,各种病理条件下UUT减压的最佳方法仍然存在争议。在这个讲座中,我们将介绍各种输尿管内置管引流的方法、适应症、禁忌症、并发症、患者的生活质量,以及输尿管内置管和经皮肾造口术的好处。
{"title":"[Decompression of upper urinary tract in various pathological conditions].","authors":"M Khokhov Z","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Obstruction of the upper urinary tract (UUT) is a heterogeneous clinical case, which, if necessary or in case of complications, is relieved by percutaneous nephrostomy or ureteral JJ-stent placement, which have its \"pros and cons\" in relation to complications, costs, difficulties in performing various pathological conditions, quality of life of patients and further treatment. The European Association of Urology Guidelines on Urolithiasis 2024 are based on the 2010s data review., fourteen years later, the optimal method of UUT decompression in various pathological conditions remains under debate. In this lecture we present methods, indications, contraindications, complications, quality of life of patients under various methods of UUT draining, as well as the benefits of ureteral stenting and percutaneous nephrostomy.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"152-161"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A complication of ureteral stenting due to incorrect tactics, leading to nephroureterectom]. 输尿管支架置入术不正确导致肾输尿管切除术的并发症。
Q4 Medicine Pub Date : 2025-03-01
V Bychkova N, V Bazaev V, A Podoinitsin A, R Setdikova G

Minimally invasive drainage of the upper urinary tract by putting ureteral stents is an accepted and widespread procedure in case of obstructive pyelonephritis and renal colic, including symptomatic upper urinary tract dilation in pregnant women. In addition, ureteral stenting has a wide range of indications in reconstructive interventions, in which it is necessary to "strengthen" the ureter for various periods of time, and is also used as a palliative measure to ensure the outflow of urine in incurable patients. At the same time, in order to avoid stent-associated complications, it is necessary to regular carefully evaluate patients, remembering the "palliative nature" of such procedures, and to correctly choose the indications for the stent placement. Our article describes combinations of problems in treatment tactics by putting ureteral stents, which led to a life-threatening purulent destructive complication and the need for nephroureterectomy.

在梗阻性肾盂肾炎和肾绞痛的情况下,包括孕妇的症状性上尿路扩张,输尿管支架对上尿路进行微创引流是一种被接受和广泛的治疗方法。此外,输尿管支架置入术在重建干预中具有广泛的适应症,需要在不同时期“加强”输尿管,也可作为一种姑息措施,以确保不治之症患者的尿液排出。同时,为了避免支架相关的并发症,有必要定期仔细评估患者,记住此类手术的“姑息性”,正确选择支架置入的适应症。我们的文章描述了输尿管支架治疗策略的综合问题,这导致了危及生命的化脓性破坏性并发症和肾输尿管切除术的需要。
{"title":"[A complication of ureteral stenting due to incorrect tactics, leading to nephroureterectom].","authors":"V Bychkova N, V Bazaev V, A Podoinitsin A, R Setdikova G","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Minimally invasive drainage of the upper urinary tract by putting ureteral stents is an accepted and widespread procedure in case of obstructive pyelonephritis and renal colic, including symptomatic upper urinary tract dilation in pregnant women. In addition, ureteral stenting has a wide range of indications in reconstructive interventions, in which it is necessary to \"strengthen\" the ureter for various periods of time, and is also used as a palliative measure to ensure the outflow of urine in incurable patients. At the same time, in order to avoid stent-associated complications, it is necessary to regular carefully evaluate patients, remembering the \"palliative nature\" of such procedures, and to correctly choose the indications for the stent placement. Our article describes combinations of problems in treatment tactics by putting ureteral stents, which led to a life-threatening purulent destructive complication and the need for nephroureterectomy.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"79-83"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficiency of treatment of complex forms of kidney stones]. [复杂形式肾结石的治疗效率]。
Q4 Medicine Pub Date : 2025-03-01
A Olkhovsky D, Yu Dalgatov Sh, G Borisenko G, N Shatokhin M, V Teodorovich O, A Naryshkin S, A Sevryukov F

Complex forms of urolithiasis, such as staghorn and multiple stones, are one of the most severe diseases of the urinary tract. The treatment is associated with high intra- and postoperative risks. These forms of nephrolithiasis are characterized by the frequent presence of residual fragments and disease recurrence, which determines the subsequent need for repeated interventions. Thus far, the choice of treatment strategy presents significant difficulties even for experienced urologists. The maximum efficiency of the treatment of complex forms of kidney stones and minimizing the incidence of complications and re-interventions determine the high scientific interest in this problem. Data reflecting the efficiency and complications of different surgical procedures in patients with complex forms of kidney stones are presented in the article.

复杂形式的尿石症,如鹿角性结石和多发性结石,是泌尿道最严重的疾病之一。该治疗存在较高的手术内和术后风险。这些形式的肾结石的特点是经常存在残留碎片和疾病复发,这决定了随后需要反复干预。到目前为止,即使对经验丰富的泌尿科医生来说,治疗策略的选择也存在很大的困难。治疗复杂形式肾结石的最大效率和最大限度地减少并发症和再次干预的发生率决定了这个问题的高度科学兴趣。数据反映效率和并发症的不同手术程序的患者与复杂形式的肾结石提出了在文章中。
{"title":"[Efficiency of treatment of complex forms of kidney stones].","authors":"A Olkhovsky D, Yu Dalgatov Sh, G Borisenko G, N Shatokhin M, V Teodorovich O, A Naryshkin S, A Sevryukov F","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Complex forms of urolithiasis, such as staghorn and multiple stones, are one of the most severe diseases of the urinary tract. The treatment is associated with high intra- and postoperative risks. These forms of nephrolithiasis are characterized by the frequent presence of residual fragments and disease recurrence, which determines the subsequent need for repeated interventions. Thus far, the choice of treatment strategy presents significant difficulties even for experienced urologists. The maximum efficiency of the treatment of complex forms of kidney stones and minimizing the incidence of complications and re-interventions determine the high scientific interest in this problem. Data reflecting the efficiency and complications of different surgical procedures in patients with complex forms of kidney stones are presented in the article.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"117-124"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Correlation of storage symptoms or overactive bladder symptoms post transurethral resection of the prostate with the duration of catheter use in a patient with urinary retention due to benign prostate hyperplasia]. [前列腺良性增生所致尿潴留患者经尿道前列腺切除术后尿潴留症状或膀胱过度活动症状与导尿管使用时间的相关性]。
Q4 Medicine Pub Date : 2025-03-01
Alfindy Perdinan Alfindy Perdinan, Alvarino Alvarino, Cimi Ilmiawati Cimi Ilmiawati, Etriyel Myh Etriyel Myh

Aim: This study aims to find out the correlation of catheter use duration with the incidence of OABS post TURP in patients with urinary retention due to BPH.

Materials and methods: An observational analytical research correlation with a cohort approach was carried out on 29 patients with urinary retention due to BPH post TURP in five hospitals in Padang from January to August 2019. Data collected included the characteristics and duration of catheter use, obtained through interviews using questionnaires, OABS were obtained based on the total score of the overactive bladder symptoms score (OABSS) standard questionnaire. The numerical variable measurement scale is between the duration of catheter use and OABSS post TURP with the Pearson test using IBM SPSS software v23.

Results: The average of catheter used duration was 14,9+/-8,0 days, and the total OABSS score was 4,7+/-2,5. Bivariate analysis showed a positive correlation with a weak strength between the duration of catheter used and the total OABSS score (Pearsons correlation, r=0,396, p=0,033). The longer the catheter is used, the higher the total OABSS.

Conclusion: The longer the catheter used increase the incidence of OABS post TURP, it is necessary to shorten the duration of catheter use to decrease the incidence and severity of OABS in urinary retention due to BPH patients post TURP.

目的:本研究旨在探讨前列腺增生所致尿潴留患者行TURP术后尿管使用时间与OABS发生率的关系。材料与方法:对2019年1 - 8月巴东5家医院29例TURP术后BPH尿潴留患者进行观察性分析研究。收集的数据包括导管使用的特征和持续时间,通过问卷访谈获得,OABS根据膀胱过度活动症状评分(OABSS)标准问卷的总分获得。数值变量测量量表介于导管使用时间与TURP后OABSS之间,采用IBM SPSS软件v23进行Pearson检验。结果:导管平均使用时间分别为14、9+/-8、0 d, OABSS总评分分别为4、7+/-2、5。双变量分析显示,导管使用时间与OABSS总评分呈正相关,且强度较弱(pearson相关性,r= 0.396, p= 0.033)。导管使用时间越长,总OABSS越高。结论:导尿管使用时间越长,术后OABS发生率越高,应缩短导尿管使用时间,以降低前列腺增生患者术后尿潴留中OABS的发生率和严重程度。
{"title":"[Correlation of storage symptoms or overactive bladder symptoms post transurethral resection of the prostate with the duration of catheter use in a patient with urinary retention due to benign prostate hyperplasia].","authors":"Alfindy Perdinan Alfindy Perdinan, Alvarino Alvarino, Cimi Ilmiawati Cimi Ilmiawati, Etriyel Myh Etriyel Myh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Aim: </strong>This study aims to find out the correlation of catheter use duration with the incidence of OABS post TURP in patients with urinary retention due to BPH.</p><p><strong>Materials and methods: </strong>An observational analytical research correlation with a cohort approach was carried out on 29 patients with urinary retention due to BPH post TURP in five hospitals in Padang from January to August 2019. Data collected included the characteristics and duration of catheter use, obtained through interviews using questionnaires, OABS were obtained based on the total score of the overactive bladder symptoms score (OABSS) standard questionnaire. The numerical variable measurement scale is between the duration of catheter use and OABSS post TURP with the Pearson test using IBM SPSS software v23.</p><p><strong>Results: </strong>The average of catheter used duration was 14,9+/-8,0 days, and the total OABSS score was 4,7+/-2,5. Bivariate analysis showed a positive correlation with a weak strength between the duration of catheter used and the total OABSS score (Pearsons correlation, r=0,396, p=0,033). The longer the catheter is used, the higher the total OABSS.</p><p><strong>Conclusion: </strong>The longer the catheter used increase the incidence of OABS post TURP, it is necessary to shorten the duration of catheter use to decrease the incidence and severity of OABS in urinary retention due to BPH patients post TURP.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"29-33"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current understanding of the urinary tract microbiome in children]. [目前对儿童尿路微生物群的认识]。
Q4 Medicine Pub Date : 2025-03-01
O Turov F, P Yatsyk S, I Krapivkin A, G Vrublevsky S, S Mamedov I, A Perevezentsev O

Introduction: The second most common reason for prescribing antibiotics in children is urinary tract infection (UTI). Since antimicrobial stewardship is a priority in the further development of strategies of the treatment of children with UTIs, the need to form an optimal model for its diagnosis and treatment is relevant in pediatric urology.

Aim: To analyze domestic and foreign publications devoted to the study of the urinary tract microbiome in children.

Results: Cultivation or culturing methods continue to be considered the "gold standard" in many countries for the diagnosis of bacterial infections, although more sensitive and specific technologies are available. A urine sample was previously considered sterile if uropathogens did not grow using standard techniques. It remains unclear whether standard microbial culturing methods are adequate to determine species diversity and identify all microorganisms capable of causing UTIs. A study of the bladder microbiome and maintenance of its homeostasis to prevent inflammatory lower urinary tract diseases is an emerging area of research. It is known that the bladder of a healthy person contains non-uropathogenic bacteria, such as Lactobacillus, which are believed to function as an immune system and protect against the effects of uropathogens.

儿童开抗生素的第二个最常见原因是尿路感染(UTI)。由于抗菌药物管理是泌尿系统感染儿童治疗策略进一步发展的优先事项,因此需要形成其诊断和治疗的最佳模型,这与儿科泌尿外科有关。目的:分析国内外有关儿童尿路微生物组研究的文献。结果:在许多国家,培养或培养方法仍然被认为是诊断细菌感染的“金标准”,尽管有更敏感和特定的技术可用。以前,如果尿路病原体没有使用标准技术生长,则尿液样本被认为是无菌的。目前尚不清楚标准的微生物培养方法是否足以确定物种多样性和识别所有能够引起尿路感染的微生物。膀胱微生物组的研究和维持其稳态以预防炎症性下尿路疾病是一个新兴的研究领域。众所周知,健康人的膀胱中含有非尿路致病菌,如乳杆菌,它们被认为具有免疫系统的功能,可以防止尿路致病菌的影响。
{"title":"[Current understanding of the urinary tract microbiome in children].","authors":"O Turov F, P Yatsyk S, I Krapivkin A, G Vrublevsky S, S Mamedov I, A Perevezentsev O","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The second most common reason for prescribing antibiotics in children is urinary tract infection (UTI). Since antimicrobial stewardship is a priority in the further development of strategies of the treatment of children with UTIs, the need to form an optimal model for its diagnosis and treatment is relevant in pediatric urology.</p><p><strong>Aim: </strong>To analyze domestic and foreign publications devoted to the study of the urinary tract microbiome in children.</p><p><strong>Results: </strong>Cultivation or culturing methods continue to be considered the \"gold standard\" in many countries for the diagnosis of bacterial infections, although more sensitive and specific technologies are available. A urine sample was previously considered sterile if uropathogens did not grow using standard techniques. It remains unclear whether standard microbial culturing methods are adequate to determine species diversity and identify all microorganisms capable of causing UTIs. A study of the bladder microbiome and maintenance of its homeostasis to prevent inflammatory lower urinary tract diseases is an emerging area of research. It is known that the bladder of a healthy person contains non-uropathogenic bacteria, such as Lactobacillus, which are believed to function as an immune system and protect against the effects of uropathogens.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"141-147"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Efficiency of the biologically active additive Oxaforin in the combined treatment of urolithiasis]. [生物活性添加剂奥沙福林联合治疗尿石症的疗效]。
Q4 Medicine Pub Date : 2025-03-01
Y Zubkov A, E Sitdykova M, A Zubkov E

Introduction: Treatment of urolithiasis remains an urgent problem related to medical, social and work rehabilitation.

Aim: To evaluate the efficiency of the biologically active additive "Oxaphorin" in the treatment of urolithiasis after extracorporeal shock-wave lithotripsy (ESWL).

Material and methods: The study included 60 male and female patients from 18 to 75 years old (average age of 45.56+/-12.49 years) with renal stones of up to 10 mm in size, which were disintegrated by the ESWL. All patients were randomized into 3 groups (20 people each). In the first group, patients received standard treatment in the postoperative period (antispasmodics, NSAIDs, uroseptics). In the second group, along with standard therapy, Oxaphorin (1 capsule 2 times a day) was administered, while in the third group Oxaphorin as monotherapy (1 capsule 2 times a day) was given. Treatment and follow-up were carried out in accordance with the study protocol for 30 days. The efficiency of treatment was assessed by the stone-free rate and time to complete evacuation of fragments. Study design included history taking, physical examination, assessment of the tolerability of therapy and adverse events, complete blood count, urinalysis, biochemical panel, ultrasound of the genitourinary system and kidney X-ray.

Results: As the study showed, the rate of stone expulsion was higher in groups of patients receiving Oxaforin. Stone-free rate after 10 days was confirmed using imaging studies and laboratory analyses in 8 (40%) patients of the first group, in 11 (55%) in the second group and in 6 (30%) in the third group. After 1 month of follow-up, stone-free status was confirmed in 16 (80%), 18 (90%) and 15 (75%) patients, respectively. In those taking Oxaforin as part of combined therapy, stone-free rate after ESWL was higher (90% vs. 75% in third group, where Oxaforin was used as monotherapy). The frequency of renal colic and its severity based on a visual analogue scale was significantly lower and less pronounced in patients receiving Oxaforin.

Conclusions: Our results showed that the biologically active additive "Oxaphorin" has a pronounced effect as medical expulsive therapy without any adverse events and is effective in patients with urinary stone disease after ESWL for kidney stones.

导读:尿石症的治疗仍然是一个亟待解决的问题,涉及到医疗、社会和工作康复。目的:评价生物活性添加剂“Oxaphorin”治疗体外冲击波碎石(ESWL)后尿石症的疗效。材料与方法:本研究纳入60例18 ~ 75岁(平均年龄45.56+/-12.49岁)肾结石≥10 mm的患者,经ESWL崩解。所有患者随机分为3组,每组20人。第一组患者在术后接受标准治疗(抗痉挛药、非甾体抗炎药、尿毒药)。第二组在标准治疗的同时给予Oxaphorin(1粒,每天2次),而第三组给予Oxaphorin单药治疗(1粒,每天2次)。按照研究方案进行治疗和随访30天。治疗的效率是通过结石的游离率和完全清除碎片的时间来评估的。研究设计包括病史记录、体格检查、治疗耐受性和不良事件评估、全血细胞计数、尿液分析、生化检查、泌尿生殖系统超声和肾脏x线检查。结果:研究显示,在接受奥沙福林治疗的患者中,结石排出率较高。第一组8例(40%),第二组11例(55%),第三组6例(30%),通过影像学检查和实验室分析证实10天后结石无结石率。随访1个月后,分别有16例(80%)、18例(90%)和15例(75%)患者确认无结石状态。在将牛沙林作为联合治疗的一部分的患者中,ESWL后无结石率更高(90% vs.第三组75%,其中使用牛沙林作为单一治疗)。基于视觉模拟量表的肾绞痛频率和严重程度在接受奥沙福林的患者中显著降低且不明显。结论:我们的研究结果表明,生物活性添加剂“Oxaphorin”作为药物排出治疗效果显著,无任何不良事件,对肾结石ESWL后尿路结石患者有效。
{"title":"[Efficiency of the biologically active additive Oxaforin in the combined treatment of urolithiasis].","authors":"Y Zubkov A, E Sitdykova M, A Zubkov E","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Treatment of urolithiasis remains an urgent problem related to medical, social and work rehabilitation.</p><p><strong>Aim: </strong>To evaluate the efficiency of the biologically active additive \"Oxaphorin\" in the treatment of urolithiasis after extracorporeal shock-wave lithotripsy (ESWL).</p><p><strong>Material and methods: </strong>The study included 60 male and female patients from 18 to 75 years old (average age of 45.56+/-12.49 years) with renal stones of up to 10 mm in size, which were disintegrated by the ESWL. All patients were randomized into 3 groups (20 people each). In the first group, patients received standard treatment in the postoperative period (antispasmodics, NSAIDs, uroseptics). In the second group, along with standard therapy, Oxaphorin (1 capsule 2 times a day) was administered, while in the third group Oxaphorin as monotherapy (1 capsule 2 times a day) was given. Treatment and follow-up were carried out in accordance with the study protocol for 30 days. The efficiency of treatment was assessed by the stone-free rate and time to complete evacuation of fragments. Study design included history taking, physical examination, assessment of the tolerability of therapy and adverse events, complete blood count, urinalysis, biochemical panel, ultrasound of the genitourinary system and kidney X-ray.</p><p><strong>Results: </strong>As the study showed, the rate of stone expulsion was higher in groups of patients receiving Oxaforin. Stone-free rate after 10 days was confirmed using imaging studies and laboratory analyses in 8 (40%) patients of the first group, in 11 (55%) in the second group and in 6 (30%) in the third group. After 1 month of follow-up, stone-free status was confirmed in 16 (80%), 18 (90%) and 15 (75%) patients, respectively. In those taking Oxaforin as part of combined therapy, stone-free rate after ESWL was higher (90% vs. 75% in third group, where Oxaforin was used as monotherapy). The frequency of renal colic and its severity based on a visual analogue scale was significantly lower and less pronounced in patients receiving Oxaforin.</p><p><strong>Conclusions: </strong>Our results showed that the biologically active additive \"Oxaphorin\" has a pronounced effect as medical expulsive therapy without any adverse events and is effective in patients with urinary stone disease after ESWL for kidney stones.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"11-16"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[En bloc resection of the large bladder tumors]. [大膀胱肿瘤整体切除]。
Q4 Medicine Pub Date : 2025-03-01
R Azilgareeva K, O Morozov A, S Taratkin M, A Gazimiev M, E Krupinov G

Transurethral resection of the bladder tumor (TURBT) is not only the main method for staging of bladder cancer, but also the standard of surgical treatment for patients with non-muscle-invasive tumosr. Previously, the generally accepted technique for performing TURBT was electroresection using loop, but the active introduction of laser technologies has made the resection of the entire tumor in a single block (en bloc) widely available. According to some authors, en bloc resection of the bladder tumor allows to overcome some limitations of standard TURBT, including insufficient quality of the specimen containing the muscle layer and implantation of floating tumor cells in the bladder. However, the en bloc resection also has limitations. When using the en bloc resection for tumors larger than 3 cm, successful evacuation of the entire lesion becomes unlikely, therefore, it is usually recommended to use it for smaller tumors. Publications devoted to the successful en bloc resection for large bladder tumors are included in the literature review. According to most authors, all the advantages of en bloc resection are preserved regardless of the tumor size, such as potentially better local control, lower recurrence rates outside the resection area, and higher quality of specimens for pathological study. A significant limitation of the technique is the inability to evacuate the tumor through the endoscope channel, which requires additional interventions (morcellation, dissection, ablation) or equipment (endoscopic baskets, forceps, etc.). Taking into account the conclusions of the Delphi consensus held in 2020, tumor size should not limit the use of the en bloc resection of the bladder tumor in the routine practice. However, an effective method for evacuating large bladder tumors that suits all specialists has not yet been proposed.

经尿道膀胱肿瘤切除术(Transurethral resection of the膀胱tumor, turt)是膀胱癌分期的主要方法,也是非肌肉侵袭性肿瘤患者手术治疗的标准。以前,执行TURBT的普遍接受的技术是使用环路电切除,但激光技术的积极引入使得在单个块(en bloc)中切除整个肿瘤广泛可用。一些作者认为,膀胱肿瘤的整体切除可以克服标准TURBT的一些局限性,包括含有肌肉层的标本质量不足和膀胱中漂浮肿瘤细胞的植入。然而,整体切除也有局限性。对于大于3cm的肿瘤采用整体切除时,不太可能成功切除整个病灶,因此通常建议对较小的肿瘤采用整体切除。文献综述中包括了关于成功的膀胱肿瘤整体切除的出版物。大多数作者认为,无论肿瘤大小如何,整体切除的所有优点都得到了保留,例如可能更好的局部控制,切除区域外的复发率更低,以及用于病理研究的标本质量更高。该技术的一个重要限制是无法通过内窥镜通道排出肿瘤,这需要额外的干预(碎裂、剥离、消融)或设备(内窥镜筐、钳等)。考虑到2020年德尔菲共识的结论,肿瘤大小不应限制膀胱肿瘤整体切除在常规实践中的应用。然而,目前还没有一种适合所有专家的有效的膀胱肿瘤切除方法。
{"title":"[En bloc resection of the large bladder tumors].","authors":"R Azilgareeva K, O Morozov A, S Taratkin M, A Gazimiev M, E Krupinov G","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Transurethral resection of the bladder tumor (TURBT) is not only the main method for staging of bladder cancer, but also the standard of surgical treatment for patients with non-muscle-invasive tumosr. Previously, the generally accepted technique for performing TURBT was electroresection using loop, but the active introduction of laser technologies has made the resection of the entire tumor in a single block (en bloc) widely available. According to some authors, en bloc resection of the bladder tumor allows to overcome some limitations of standard TURBT, including insufficient quality of the specimen containing the muscle layer and implantation of floating tumor cells in the bladder. However, the en bloc resection also has limitations. When using the en bloc resection for tumors larger than 3 cm, successful evacuation of the entire lesion becomes unlikely, therefore, it is usually recommended to use it for smaller tumors. Publications devoted to the successful en bloc resection for large bladder tumors are included in the literature review. According to most authors, all the advantages of en bloc resection are preserved regardless of the tumor size, such as potentially better local control, lower recurrence rates outside the resection area, and higher quality of specimens for pathological study. A significant limitation of the technique is the inability to evacuate the tumor through the endoscope channel, which requires additional interventions (morcellation, dissection, ablation) or equipment (endoscopic baskets, forceps, etc.). Taking into account the conclusions of the Delphi consensus held in 2020, tumor size should not limit the use of the en bloc resection of the bladder tumor in the routine practice. However, an effective method for evacuating large bladder tumors that suits all specialists has not yet been proposed.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"136-140"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acute kidney injury due to retroperitoneal fibrosis: complexities of diagnosis and treatment]. [腹膜后纤维化所致急性肾损伤:诊断和治疗的复杂性]。
Q4 Medicine Pub Date : 2025-03-01
N Vetchinnikova O, P Suslov V, A Stepanova E, V Dutov V

Retroperitoneal fibrosis (RPF) is a rare cause of postrenal acute kidney injury (AKI). We present a clinical case of a 65-year-old patient who developed acute right-sided hydronephrosis with postrenal AKI. Contrast-enhanced computed tomography showed dilation of the ureter, pelvis and calyxes on the right, diminished size of the left kidney and signs of RPF, including fat tissue thickening, compaction and stranding along the aorta and its visceral branches, mesenteric sinuses, thickening of the peritoneum at the level of the paracolic gutters, pelvic tissue compaction, descending and infrarenal abdominal aortic aneurisms, subocclusion of the left renal artery, and atherosclerosis of the visceral arteries. The patient received hemodialysis. IgG4-related RPF was diagnosed. A 6Ch/24 cm stent was placed in the right ureter, after that AKI resolved. Patients with RPF require multidisciplinary approach for timely diagnosis and successful treatment.

腹膜后纤维化(RPF)是肾后急性肾损伤(AKI)的罕见原因。我们提出一个65岁的临床病例,病人发展为急性右侧肾后肾性肾衰。增强计算机断层扫描显示右侧输尿管、骨盆和肾盏扩张,左肾体积缩小,RPF症状包括脂肪组织增厚、压实和沿主动脉及其内脏分支、肠系膜窦、腹膜在结肠旁沟水平增厚、盆腔组织压实、下行和肾下腹主动脉瘤、左肾动脉亚闭合。以及内脏动脉粥样硬化。患者接受了血液透析。诊断为igg4相关RPF。在右侧输尿管放置6Ch/ 24cm支架,AKI消退。RPF患者需要多学科的方法来及时诊断和成功治疗。
{"title":"[Acute kidney injury due to retroperitoneal fibrosis: complexities of diagnosis and treatment].","authors":"N Vetchinnikova O, P Suslov V, A Stepanova E, V Dutov V","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Retroperitoneal fibrosis (RPF) is a rare cause of postrenal acute kidney injury (AKI). We present a clinical case of a 65-year-old patient who developed acute right-sided hydronephrosis with postrenal AKI. Contrast-enhanced computed tomography showed dilation of the ureter, pelvis and calyxes on the right, diminished size of the left kidney and signs of RPF, including fat tissue thickening, compaction and stranding along the aorta and its visceral branches, mesenteric sinuses, thickening of the peritoneum at the level of the paracolic gutters, pelvic tissue compaction, descending and infrarenal abdominal aortic aneurisms, subocclusion of the left renal artery, and atherosclerosis of the visceral arteries. The patient received hemodialysis. IgG4-related RPF was diagnosed. A 6Ch/24 cm stent was placed in the right ureter, after that AKI resolved. Patients with RPF require multidisciplinary approach for timely diagnosis and successful treatment.</p>","PeriodicalId":23546,"journal":{"name":"Urologiia","volume":" 1","pages":"84-88"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologiia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1